Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: VLAD who wrote (17837)	1/17/1999 8:07:00 AM
From: Frostman	Respond to of 23519

Vlad, well maybe he'd like to print a clarification. What he wrote for Marketwatch: <<Changing technologies The industries have their similarities, however. Fortunes for several biotech companies waned because of new developments that made their research obsolete. Just look at Vivus (VVUS), the maker of the Muse impotency product. The development of Pfizer's (PFE) Viagra pill sent shares of Vivus skidding into the low single-digits, down from a high of 40-plus in 1997. >> His response to you: <<Appreciate your comments. While the sentence before the Vivus example could have led you to believe that I was calling the MUSE technology obsolete, that was not the case. I was just looking for a good example of one biotech product that was enjoying great success before another one came along and took away much of its sales -- and was given that example by another doctor.>> Frostman